Structural White and Gray Matter Correlates of Impaired Muscle Control and Deficient Pain Processing
Conditions: Low Back Pain; Low Back Pain, Recurrent; Low Back Pain, Chronic; Healthy Volunteers; Fibromyalgia Sponsors: University Ghent; Fund for Scientific Research, Flanders, Belgium Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
Leuven, BELGIUM, Boston, MA, US– November 20, 2023– 7:00 am CET– Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company announced today that topline data in its KALAHARI Phase 2, Part B clinical trial for diabetic... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 20, 2023 Category: Pharmaceuticals Source Type: clinical trials
Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Conditions: Mpox Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; National Institute of Allergy and Infectious Diseases (NIAID); Leidos Biomedical Research, Inc.; Alliance for International Medical Action; University of California, Los Angeles; Institut de Recherche pour le Developpement; University of Manito ba Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity of Ervebo ® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
Conditions: Ebola Virus Disease Interventions: Drug: Zabdeno ® booster; Drug: Ervebo® booster Sponsors: Institute of Tropical Medicine, Belgium; Institut National pour la Recherche Biomedicale (INRB) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Febrile Illness in Guinea
Conditions: Febrile Illness Sponsors: Centre National de Formation et de Recherche en Sante Rurale; Institute of Tropical Medicine, Belgium Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD
Conditions: Parkinson Disease; Dementia With Lewy Bodies; MSA - Multiple System Atrophy; Alzheimer Disease Interventions: Diagnostic Test: [18F]-MFBG PET CT; Diagnostic Test: [18F]-FE-PE2I PET CT or PET MRI; Diagnostic Test: [123I]-MIBG SPECT CT; Diagnostic Test: [18F]-MFBG PET dosimetry scans Sponsors: prof. dr. Koen Van Laere; University Hospital, Ghent; Fund for Scientific Research, Flanders, Belgium; KU Leuven; Universitaire Ziekenhuizen KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis Interventions: Drug: Infliximab; Drug: Infliximab; Drug: Infliximab Sponsors: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW; Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Colchicine 0.5 MG Oral Tablet; Drug: Placebo Sponsors: AZ Sint-Jan AV; University Hospital, Ghent; Belgium Health Care Knowledge Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries
Conditions: Congenital Heart Disease; Coronary Artery Anomaly; Sudden Cardiac Death; Surgical Procedure, Unspecified; Diagnosis; Arrhythmia; Heart Defects, Congenital; Adult Children Interventions: Procedure: unroofing or other surgery if needed Sponsors: University of Padova; IRCCS Policlinico S. Donato; Mitera Children ' s Hospital, Athens Heart Surgery Institute, Greece; Ospedale Civile Ca ' Foncello; University Hospital, Ghent; Guy ' s and St Thomas ' NHS Foundation Trust; Azienda Ospedaliera Universitaria Integrata Verona; University Medical Center Groningen; Hospital Universitario La Paz; Cliniques universitaires Sai...
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Belgian Registry on Coronary Function Testing
Conditions: Coronary Microvascular Dysfunction; Coronary Artery Vasospasm Interventions: Diagnostic Test: Coronary Function Test Sponsors: University Hospital, Antwerp Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Towards a Food Ingredient Clinically Proven to Benefit Gut Health: Novel RG-I Variants
Conditions: Healthy Interventions: Dietary Supplement: Maltodextrin; Dietary Supplement: Chicory RG-I; Dietary Supplement: Carrot RG-I Sponsors: Örebro University, Sweden; NutriLeads B.V. (Wageningen, The Netherlands); ProDigest (Ghent, Belgium); Ambiotis (Toulouse, France) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial)
DiscussionDoxapram has the potential to improve neonatal outcomes by improving respiration, but the safety concerns need to be weighed against the potential risks of invasive mechanical ventilation. It is unknown if the use of doxapram improves the long-term outcome. This forms the clinical equipoise of the current trial. This international, multicentre trial will provide the needed high-quality evidence on the efficacy and safety of doxapram in the treatment of AOP in preterm infants.Trial registrationClinicalTrials.gov NCT04430790 and EUDRACT 2019-003666-41. Prospectively registered on respectively June and January 2020. (Source: Trials)
Source: Trials - October 10, 2023 Category: Research Source Type: clinical trials
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Conditions: Sexual Conversion of Plasmodium Falciparum; Single Cell RNA-sequencing (scRNA-seq); Untargeted Metabolomics; Transmission; Immune Factors Sponsors: Institute of Tropical Medicine, Belgium; Instituto Nacional de Sa úde, Mozambique; Clinical Research Unit of Nanoro (CRUN), Burkina Faso; Barcelona Institute for Global Health; Leiden University Medical Center; KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
Conditions: Soil Transmitted Helminths; Schistosomiasis Mansoni Intervention: Diagnostic Test: Artificial Intelligence Digital Pathology Sponsors: Enaiblers AB; Jimma University; Ministry of Health, Uganda; Ghent University, Belgium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
